We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App


ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.
16 Feb 2023 - 18 Feb 2023

Point of Care Microscope Helps Identify Cancer Cells

By HospiMedica International staff writers
Posted on 08 Feb 2016
Print article
Image: The handheld MEMS microscope (Photo courtesy of Dennis Wise/University of Washington).
Image: The handheld MEMS microscope (Photo courtesy of Dennis Wise/University of Washington).
A handheld miniature microscope could examine tissues at the cellular level right in the operating room, helping surgeons determine the extent of tumor resection.

Developed by researchers at the University of Washington (UW; Seattle, USA), Memorial Sloan-Kettering Cancer Center (MSKCC; New York, NY, USA), and other institutions, the microelectromechanical systems (MEMS) line-scanned (LS) dual-axis confocal (DAC) microscope has a 12-mm diameter distal tip specifically developed for clinical point-of-care (POC) pathology examination. The dual-axis architecture surpasses conventional, single-axis confocal configuration by reducing the background noise generated by out-of-focus images and scattered light.

The use of line scanning enables scan rates of at least 16 frames per second (FPS), which helps mitigate motion artifacts common when using hand-held devices. The researcher also developed a method to actively align the illumination and collection beams in a DAC microscope through the use of a pair of rotatable alignment mirrors. Finally, the incorporation of a custom objective lens with a small form factor enables the device to achieve an optical-sectioning thickness of 2 micrometers with a lateral resolution of just 1.1 micrometers.

The researchers successfully demonstrated that the miniature POC microscope has sufficient resolution to see subcellular details, comparable to those produced from a multi-day process at a clinical pathology lab, which is the current gold standard for identifying cancerous cells. They hope that after testing the microscope’s performance as a human cancer-screening tool in vivo, it could be used during surgeries or other clinical procedures within the next 2-4 years. The study describing the development process was published in the January 2016 issue of Biomedical Optics Express.

“Surgeons don’t have a very good way of knowing when they’re done cutting out a tumor. They’re using their sense of sight, their sense of touch, preoperative images of the brain, and oftentimes it’s pretty subjective,” said senior author Jonathan Liu, PHD, a UW assistant professor of mechanical engineering. “Being able to zoom and see at the cellular level during the surgery would really help them to accurately differentiate between tumor and normal tissues and improve patient outcomes.”

“The microscope technologies that have been developed over the last couple of decades are expensive and still pretty large, about the size of a hair dryer or a small dental X-ray machine,” added study coauthor Milind Rajadhyaksha, MD, of MSKCC. “So there’s a need for creating much more miniaturized microscopes. Making microscopes smaller, however, usually requires sacrificing some aspect of image quality or performance such as resolution, field of view, depth, imaging contrast or processing speed.”

Related Links:

University of Washington
Memorial Sloan-Kettering Cancer Center
Stanford University

Gold Supplier
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Analgesic Gas Delivery System
O-Two Equinox Advantage
Orthopedic Table
GS GS-HV Series
High Frequency X-Ray Generator

Print article



view channel
Image: MyoVista Wavelet technology utilizes AI for early detection of heart disease (Photo courtesy of Heart Test Laboratories)

Novel ECG Technology Utilizes AI for Early Detection of Heart Disease

Cardiovascular disease is responsible for 17.9 million deaths every year, or about 32% of all deaths worldwide. Every week, millions of electrocardiographs (ECGs) are performed across the world, making... Read more

Critical Care

view channel
Image: Studies have shown the Autus Valve maintains control of blood flow as it expands (Photo courtesy of Boston Children’s Hospital)

Heart Valve That Grows Along With Child Could Reduce Invasive Surgeries

In children with congenital pulmonary valve disease, the flow of blood between the heart and lungs is impeded. In cases where the pulmonary valves have narrowed or are leaking and cannot be treated effectively... Read more

Health IT

view channel
Image: Using digital data can improve health outcomes (Photo courtesy of Unsplash)

Electronic Health Records May Be Key to Improving Patient Care, Study Finds

When a patient gets transferred from a hospital to a nearby specialist or rehabilitation facility, it is often difficult for personnel at the new facility to access the patient’s electronic health records... Read more

Point of Care

view channel
Image: Steripath improves the diagnostic accuracy and timeliness of sepsis test results (Photo courtesy of Magnolia)

All-in-One Device Reduces False-Positive Diagnostic Test Results for Bloodstream Infections

Blood cultures are considered the gold standard diagnostic test for the detection of blood stream infections, such as sepsis. However, positive blood culture results can be frequently wrong, and about... Read more


view channel
Image: The global patient positioning systems market is projected to reach USD 1.7 billion by 2027 (Photo courtesy of Pexels)

Global Patient Positioning Systems Market Driven by Increasing Chronic Diseases

The global patient positioning systems market is projected to grow at a CAGR of 4% from USD 1.4 billion in 2022 to USD 1.7 billion by 2027, driven by increasing technological advancements in medical devices,... Read more
Copyright © 2000-2023 Globetech Media. All rights reserved.